2020 - FDA and MHRA Guidance during the COVID-19 Emergency: Conduct of Clinical Trials
Date2020-05-20
Deadline2020-05-10
VenueOnline Event, USA - United States
KeywordsCovid -19 impact; Clinical trials disruption; Mhra guidance for covid-19
Topics/Call fo Papers
Safeguarding patient safety
Alternative approaches for products normally administered at the clinic
Informed consent by quarantined patients
Availability of clinical trial supplies
Subject enrollment
Handling protocol deviations
Approval of protocol amendments
Monitoring of trial participants
Access to medical records
Pausing clinical trials
Alternative approaches for products normally administered at the clinic
Informed consent by quarantined patients
Availability of clinical trial supplies
Subject enrollment
Handling protocol deviations
Approval of protocol amendments
Monitoring of trial participants
Access to medical records
Pausing clinical trials
Other CFPs
Last modified: 2020-05-06 00:02:40